Noom
Behavioral-psychology weight-loss app now bundled with GLP-1 prescriptions via Noom Med
Health Tech
📍 New York, NY
Founded 2008
Current Valuation
$3.7B
as of 2024-Q2
UNICORN
Noom is a New York-based behavioral-psychology weight-loss app founded in 2008 by Saeju Jeong and Artem Petakov, best known for pairing CBT-style coaching with calorie and habit tracking. The 2021 Series F led by Silver Lake (with Sequoia and Temasek) valued the company at $3.7B on $540M of fresh capital — the high-water mark. In 2024 Geoff Cook succeeded Saeju Jeong as CEO and pivoted Noom into the GLP-1 wave via Noom Med, bundling behavioral coaching with semaglutide/tirzepatide prescription telehealth, which has become the company's fastest-growing surface as Ozempic and Mounjaro adoption explode.
Company Profile
Growth
~25% growth in 2023 to ~$1B revenue; pivoted to Noom Med (GLP-1 prescription telehealth) under new CEO Geoff Cook in 2024
Last Round
Series F — $540M (May 2021) · Lead: Silver Lake
Founders & Key People
Saeju JeongArtem Petakov
Investors
Silver Lake · Sequoia Capital · Temasek · RRE Ventures · Oak HC/FT · Samsung Ventures · Serena Ventures
Products
- Noom Weight (behavioral CBT app for weight loss)
- Noom Med (GLP-1 prescription telehealth)
- Noom for Diabetes
- Noom Mood (mental wellness)
- Noom Family
Competitors
WW International (WW) · Hims & Hers Health (HIMS) · Ro · Calibrate · Found · Eli Lilly Direct (LLY)
TelehealthGLP-1Weight LossConsumer HealthBehavioral Health
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q2. Refreshed quarterly.